European regulatory experience with drugs for central nervous system disorders

Nat Rev Drug Discov. 2015 Feb;14(2):89-90. doi: 10.1038/nrd4511. Epub 2014 Dec 19.

Authors

Florence Butlen-Ducuing¹, Malgorzata Zienowicz¹, Frank Pétavy¹, Manuel Haas¹, Tomas Salmonson², Hans-Georg Eichler¹, Guido Rasi¹

Affiliations

¹ European Medicines Agency, 30 Churchill Place, Canary Wharf, London E14 5EU, United Kingdom.
² Medical Products Agency, SE-751 03 Uppsala, Sweden, and is Chair of the CHMP.

PMID: 25524018
DOI: 10.1038/nrd4511

No abstract available

MeSH terms

Central Nervous System Agents / economics
Central Nervous System Agents / standards*
Central Nervous System Diseases / drug therapy*
Drug Approval* / legislation & jurisprudence
Drug Approval* / statistics & numerical data
Europe
Government Regulation*
Humans
Marketing / legislation & jurisprudence

Substances

Central Nervous System Agents